New psoriasis pill shows promise in Mid-Stage trial

NCT ID NCT06542614

Completed Symptom relief Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called TQH3906 in 209 adults with moderate to severe plaque psoriasis. The goal was to see if it could safely clear skin patches and improve symptoms over 12 weeks. Researchers measured how much skin improved using standard psoriasis scores.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

psoriasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PLAQUE PSORIASIS

Contacts and locations

Locations

Affiliated Hangzhou First People'S Hospital,School of Medicine, Westlake University

Hangzhou, Zhejiang, 310003, China
Beijing Tongren Hospital, Capital Medical University

Beijing, Beijing Municipality, 100730, China
Dermatology Hospital of Southern Medical University

Guangzhou, Guangdong, 510091, China
Genertec Liaoyou Gem Flower Hospital

Panjin, Liaoning, 124000, China
Heilongjiang Provincial Hospital

Harbin, Heilongjiang, 150036, China
Hospital of Dermatology, Chinese Academy of Medical Sciences

Nanjing, Jiangsu, 210000, China
Liuzhou People'S Hospital

Liuzhou, Guangxi, 545006, China
Meihekou Central Hospital

Meihekou, Jilin, 135000, China
Nanyang First People'S Hospital

Nanyang, Henan, 473010, China
Qingdao Municipal hospital (group)

Qingdao, Shandong, 266011, China
Qingdao Traditional Chinese Medicine Hospital

Qingdao, Shandong, 266033, China
Shandong First Medical University Affiliated Dermatology Hospital

Jinan, Shandong, 250022, China
Shandong University Qilu Hospital

Jinan, Shandong, 250063, China
Shanghai JiaoTong University of medicine Ruijin Hospital

Shanghai, Shanghai Municipality, 20025, China
Shanxi Provincial People's Hospital

Taiyuan, Shanxi, 030012, China
Shengjing Hospital of China Medical University

Shenyang, Liaoning, 110000, China
Shijiazhuang Hospital of Traditional Chinese Medicine

Shijiazhuang, Hebei, 50000, China
Shiyan Renmin Hospital

Shiyan, Hubei, 442000, China
The First Affiliated Hospital of Baotou Medical College

Baotou, Inner Mongolia, 014000, China
The First Affiliated Hospital of Soochow University

Suzhou, Jiangsu, 215006, China
The First Bethune Hospital of Jilin University

Changchun, Jilin, 130031, China
The First People's Hospital of Changde

Changde, Hunan, 415100, China
The Second Affiliated Hospital Of Xingtai Medical Colledge

Xingtai, Hebei, 054002, China
The Second Affiliated Hospital Zhejiang University School Of Medicine

Hangzhou, Zhejiang, 310009, China
The Second Affiliated Hospital of Henan University of Science and Technology

Luoyang, Henan, 471000, China
The Second Affiliated Hospital of Wannan Medical College

Wuhu, Anhui, 241000, China
The Second Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710000, China
The Second Hospital of HeBei Medical University

Shijiazhuang, Hebei, 50000, China
The Third Xiangya Hospital of Central South University

Changsha, Hunan, 410000, China
The first affiliated hospital of chongqing medical university

Chongqing, Chongqing Municipality, 400042, China
The first hospital of china medical university

Shenyang, Liaoning, 110001, China
Tianjin Academy of Traditional Chinese Medicine Affiliated Hospital

Tianjin, Tianjin Municipality, 300120, China
Wuhan First Hospital

Wuhan, Hubei, 430033, China
Xinjiang Uygur Autonomous Region People's Hospital

Ürümqi, Xinjiang, 830001, China
Yancheng First People's Hospital

Yancheng, Jiangsu, 224006, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.